Logo image of CCJ

CAMECO CORP (CCJ) Stock Fundamental Analysis

NYSE:CCJ - New York Stock Exchange, Inc. - CA13321L1085 - Common Stock - Currency: USD

50.32  +2.87 (+6.05%)

After market: 50.34 +0.02 (+0.04%)

Fundamental Rating

4

Taking everything into account, CCJ scores 4 out of 10 in our fundamental rating. CCJ was compared to 212 industry peers in the Oil, Gas & Consumable Fuels industry. CCJ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CCJ is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CCJ was profitable.
In the past year CCJ had a positive cash flow from operations.
In multiple years CCJ reported negative net income over the last 5 years.
In the past 5 years CCJ always reported a positive cash flow from operatings.
CCJ Yearly Net Income VS EBIT VS OCF VS FCFCCJ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M

1.2 Ratios

CCJ has a Return On Assets of 1.25%. This is in the lower half of the industry: CCJ underperforms 70.87% of its industry peers.
The Return On Equity of CCJ (1.88%) is worse than 70.87% of its industry peers.
CCJ's Return On Invested Capital of 2.95% is on the low side compared to the rest of the industry. CCJ is outperformed by 72.82% of its industry peers.
Industry RankSector Rank
ROA 1.25%
ROE 1.88%
ROIC 2.95%
ROA(3y)1.1%
ROA(5y)0.72%
ROE(3y)1.78%
ROE(5y)1.15%
ROIC(3y)N/A
ROIC(5y)N/A
CCJ Yearly ROA, ROE, ROICCCJ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 -2 4 -4

1.3 Margins

The Profit Margin of CCJ (4.17%) is worse than 64.56% of its industry peers.
In the last couple of years the Profit Margin of CCJ has grown nicely.
CCJ's Operating Margin of 12.49% is on the low side compared to the rest of the industry. CCJ is outperformed by 61.65% of its industry peers.
CCJ's Operating Margin has improved in the last couple of years.
CCJ's Gross Margin of 23.81% is on the low side compared to the rest of the industry. CCJ is outperformed by 65.53% of its industry peers.
In the last couple of years the Gross Margin of CCJ has grown nicely.
Industry RankSector Rank
OM 12.49%
PM (TTM) 4.17%
GM 23.81%
OM growth 3YN/A
OM growth 5Y26.02%
PM growth 3YN/A
PM growth 5Y11.89%
GM growth 3Y54.28%
GM growth 5Y8.95%
CCJ Yearly Profit, Operating, Gross MarginsCCJ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20

6

2. Health

2.1 Basic Checks

CCJ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CCJ has more shares outstanding
The number of shares outstanding for CCJ has been increased compared to 5 years ago.
Compared to 1 year ago, CCJ has a worse debt to assets ratio.
CCJ Yearly Shares OutstandingCCJ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
CCJ Yearly Total Debt VS Total AssetsCCJ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

2.2 Solvency

CCJ has an Altman-Z score of 6.91. This indicates that CCJ is financially healthy and has little risk of bankruptcy at the moment.
CCJ's Altman-Z score of 6.91 is amongst the best of the industry. CCJ outperforms 92.23% of its industry peers.
The Debt to FCF ratio of CCJ is 3.27, which is a good value as it means it would take CCJ, 3.27 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CCJ (3.27) is better than 69.42% of its industry peers.
CCJ has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
CCJ has a better Debt to Equity ratio (0.20) than 67.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 3.27
Altman-Z 6.91
ROIC/WACC0.39
WACC7.56%
CCJ Yearly LT Debt VS Equity VS FCFCCJ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.88 indicates that CCJ has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.88, CCJ belongs to the best of the industry, outperforming 80.58% of the companies in the same industry.
CCJ has a Quick Ratio of 1.26. This is a normal value and indicates that CCJ is financially healthy and should not expect problems in meeting its short term obligations.
CCJ has a Quick ratio of 1.26. This is in the better half of the industry: CCJ outperforms 63.11% of its industry peers.
Industry RankSector Rank
Current Ratio 2.88
Quick Ratio 1.26
CCJ Yearly Current Assets VS Current LiabilitesCCJ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

5

3. Growth

3.1 Past

CCJ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.85%.
Measured over the past 5 years, CCJ shows a small growth in Earnings Per Share. The EPS has been growing by 7.91% on average per year.
Looking at the last year, CCJ shows a very strong growth in Revenue. The Revenue has grown by 23.31%.
Measured over the past years, CCJ shows a small growth in Revenue. The Revenue has been growing by 4.35% on average per year.
EPS 1Y (TTM)-29.85%
EPS 3YN/A
EPS 5Y7.91%
EPS Q2Q%-103.12%
Revenue 1Y (TTM)23.31%
Revenue growth 3Y12.86%
Revenue growth 5Y4.35%
Sales Q2Q%25.32%

3.2 Future

The Earnings Per Share is expected to grow by 30.81% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 7.27% on average over the next years.
EPS Next Y-24.87%
EPS Next 2Y43.68%
EPS Next 3Y38.82%
EPS Next 5Y30.81%
Revenue Next Year18.81%
Revenue Next 2Y14.56%
Revenue Next 3Y11.86%
Revenue Next 5Y7.27%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CCJ Yearly Revenue VS EstimatesCCJ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
CCJ Yearly EPS VS EstimatesCCJ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

CCJ is valuated quite expensively with a Price/Earnings ratio of 157.25.
Compared to the rest of the industry, the Price/Earnings ratio of CCJ indicates a slightly more expensive valuation: CCJ is more expensive than 75.24% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.47. CCJ is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 45.20, which means the current valuation is very expensive for CCJ.
70.87% of the companies in the same industry are cheaper than CCJ, based on the Price/Forward Earnings ratio.
CCJ is valuated cheaply when we compare the Price/Forward Earnings ratio to 92.74, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 157.25
Fwd PE 45.2
CCJ Price Earnings VS Forward Price EarningsCCJ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CCJ is valued a bit more expensive than 79.13% of the companies in the same industry.
61.65% of the companies in the same industry are cheaper than CCJ, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 83.12
EV/EBITDA 54.8
CCJ Per share dataCCJ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as CCJ's earnings are expected to grow with 38.82% in the coming years.
PEG (NY)N/A
PEG (5Y)19.89
EPS Next 2Y43.68%
EPS Next 3Y38.82%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.22%, CCJ is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.57, CCJ is paying slightly less dividend.
With a Dividend Yield of 0.22, CCJ pays less dividend than the S&P500 average, which is at 2.28.
Industry RankSector Rank
Dividend Yield 0.22%

5.2 History

The dividend of CCJ decreases each year by -7.75%.
CCJ has paid a dividend for at least 10 years, which is a reliable track record.
CCJ has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-7.75%
Div Incr Years1
Div Non Decr Years6
CCJ Yearly Dividends per shareCCJ Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0 0 0 0

5.3 Sustainability

CCJ pays out 44.71% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP44.71%
EPS Next 2Y43.68%
EPS Next 3Y38.82%
CCJ Yearly Income VS Free CF VS DividendCCJ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M
CCJ Dividend Payout.CCJ Dividend Payout, showing the Payout Ratio.CCJ Dividend Payout.PayoutRetained Earnings

CAMECO CORP

NYSE:CCJ (2/4/2025, 6:40:00 PM)

After market: 50.34 +0.02 (+0.04%)

50.32

+2.87 (+6.05%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-20 2025-02-20/amc
Inst Owners76.29%
Inst Owner Change-0.31%
Ins Owners0.42%
Ins Owner ChangeN/A
Market Cap21.90B
Analysts82.67
Price Target84.34 (67.61%)
Short Float %3.56%
Short Ratio3.79
Dividend
Industry RankSector Rank
Dividend Yield 0.22%
Yearly Dividend0.12
Dividend Growth(5Y)-7.75%
DP44.71%
Div Incr Years1
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-75.2%
Min EPS beat(2)-103.96%
Max EPS beat(2)-46.43%
EPS beat(4)0
Avg EPS beat(4)-52.63%
Min EPS beat(4)-103.96%
Max EPS beat(4)-5.49%
EPS beat(8)3
Avg EPS beat(8)-10.58%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.28%
Min Revenue beat(2)-22.8%
Max Revenue beat(2)-3.76%
Revenue beat(4)1
Avg Revenue beat(4)-11.5%
Min Revenue beat(4)-22.8%
Max Revenue beat(4)2.54%
Revenue beat(8)3
Avg Revenue beat(8)-6.5%
Revenue beat(12)5
Avg Revenue beat(12)-3.36%
Revenue beat(16)6
Avg Revenue beat(16)-2.42%
PT rev (1m)1.58%
PT rev (3m)8.1%
EPS NQ rev (1m)0.73%
EPS NQ rev (3m)-20.46%
EPS NY rev (1m)0.23%
EPS NY rev (3m)-33.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)19.32%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.63%
Valuation
Industry RankSector Rank
PE 157.25
Fwd PE 45.2
P/S 11.47
P/FCF 83.12
P/OCF 55.62
P/B 5.17
P/tB 5.2
EV/EBITDA 54.8
EPS(TTM)0.32
EY0.64%
EPS(NY)1.11
Fwd EY2.21%
FCF(TTM)0.61
FCFY1.2%
OCF(TTM)0.9
OCFY1.8%
SpS4.39
BVpS9.74
TBVpS9.67
PEG (NY)N/A
PEG (5Y)19.89
Profitability
Industry RankSector Rank
ROA 1.25%
ROE 1.88%
ROCE 3.99%
ROIC 2.95%
ROICexc 3.02%
ROICexgc 3.04%
OM 12.49%
PM (TTM) 4.17%
GM 23.81%
FCFM 13.8%
ROA(3y)1.1%
ROA(5y)0.72%
ROE(3y)1.78%
ROE(5y)1.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y23.63%
ROICexc growth 3YN/A
ROICexc growth 5Y23.76%
OM growth 3YN/A
OM growth 5Y26.02%
PM growth 3YN/A
PM growth 5Y11.89%
GM growth 3Y54.28%
GM growth 5Y8.95%
F-Score5
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 3.27
Debt/EBITDA 2.21
Cap/Depr 85.85%
Cap/Sales 6.82%
Interest Coverage 4.25
Cash Conversion 100.93%
Profit Quality 331.39%
Current Ratio 2.88
Quick Ratio 1.26
Altman-Z 6.91
F-Score5
WACC7.56%
ROIC/WACC0.39
Cap/Depr(3y)67.49%
Cap/Depr(5y)53.38%
Cap/Sales(3y)6.77%
Cap/Sales(5y)5.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.85%
EPS 3YN/A
EPS 5Y7.91%
EPS Q2Q%-103.12%
EPS Next Y-24.87%
EPS Next 2Y43.68%
EPS Next 3Y38.82%
EPS Next 5Y30.81%
Revenue 1Y (TTM)23.31%
Revenue growth 3Y12.86%
Revenue growth 5Y4.35%
Sales Q2Q%25.32%
Revenue Next Year18.81%
Revenue Next 2Y14.56%
Revenue Next 3Y11.86%
Revenue Next 5Y7.27%
EBIT growth 1Y67.54%
EBIT growth 3YN/A
EBIT growth 5Y31.5%
EBIT Next Year280.2%
EBIT Next 3Y79.45%
EBIT Next 5Y47.57%
FCF growth 1Y177.09%
FCF growth 3YN/A
FCF growth 5Y-2.67%
OCF growth 1Y101.64%
OCF growth 3Y129.54%
OCF growth 5Y0.61%